ATE280767T1 - Antidiabetische thiazolidindione und ihre herstellung - Google Patents

Antidiabetische thiazolidindione und ihre herstellung

Info

Publication number
ATE280767T1
ATE280767T1 AT00985704T AT00985704T ATE280767T1 AT E280767 T1 ATE280767 T1 AT E280767T1 AT 00985704 T AT00985704 T AT 00985704T AT 00985704 T AT00985704 T AT 00985704T AT E280767 T1 ATE280767 T1 AT E280767T1
Authority
AT
Austria
Prior art keywords
antidiabetic
thiazolidindiones
production
chem
meaning
Prior art date
Application number
AT00985704T
Other languages
English (en)
Inventor
Janos Fischer
Tamas Fodor
Sandor Levai
Ildiko Ballo
Endrene Petenyi
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of ATE280767T1 publication Critical patent/ATE280767T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Processing Of Stones Or Stones Resemblance Materials (AREA)
AT00985704T 1999-12-18 2000-12-14 Antidiabetische thiazolidindione und ihre herstellung ATE280767T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9904634A HU225919B1 (en) 1999-12-18 1999-12-18 Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
PCT/HU2000/000129 WO2001044240A1 (en) 1999-12-18 2000-12-14 Antidiabetic thiazolidinediones and their preparation

Publications (1)

Publication Number Publication Date
ATE280767T1 true ATE280767T1 (de) 2004-11-15

Family

ID=90000182

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00985704T ATE280767T1 (de) 1999-12-18 2000-12-14 Antidiabetische thiazolidindione und ihre herstellung

Country Status (6)

Country Link
EP (2) EP1242418B1 (de)
AT (1) ATE280767T1 (de)
AU (1) AU2210401A (de)
DE (1) DE60015390T9 (de)
HU (1) HU225919B1 (de)
WO (1) WO2001044240A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
JP4573978B2 (ja) 2000-09-19 2010-11-04 キヤノン株式会社 画像形成装置
GB0023971D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical
GB0023970D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical
WO2002051823A1 (en) * 2000-12-26 2002-07-04 Torrent Pharmaceuticals Ltd Process for the preparation of rosiglitazone maleate
GB0129851D0 (en) * 2001-12-13 2002-01-30 Smithkline Beecham Plc Novel compounds
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
AR047541A1 (es) * 2004-02-13 2006-01-25 Sandoz Ag Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
GB2413795A (en) * 2004-05-05 2005-11-09 Cipla Ltd Process for the preparation of rosiglitazone
CA2566352A1 (en) * 2004-05-12 2005-11-17 Medichem S.A. Process for the preparation of rosiglitazone
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
HUP0600517A3 (en) * 2006-06-23 2008-10-28 Richter Gedeon Nyrt Process for the production of benzylidene-rosiglitazone base
HUP0800755A2 (en) 2008-12-11 2010-09-28 Richter Gedeon Nyrt Crystalline forms of rosiglitazone
DE102009053562A1 (de) 2009-11-18 2011-05-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Rosiglitazonsuccinat enthaltende pharmazeutische Zusammensetzung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (de) * 1987-09-04 1998-05-20 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
GB0023970D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
HU225919B1 (en) 2007-12-28
EP1242418A1 (de) 2002-09-25
EP1242418B1 (de) 2004-10-27
HU9904634D0 (en) 2000-02-28
DE60015390D1 (de) 2004-12-02
HUP9904634A2 (hu) 2002-01-28
WO2001044240A1 (en) 2001-06-21
AU2210401A (en) 2001-06-25
DE60015390T9 (de) 2006-01-26
EP1475378A1 (de) 2004-11-10
DE60015390T2 (de) 2005-10-13

Similar Documents

Publication Publication Date Title
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
ATE280767T1 (de) Antidiabetische thiazolidindione und ihre herstellung
DE69915004D1 (de) 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
WO2004024777A8 (en) Hydroxyalkyl starch derivatives
DK1613304T3 (da) DPP-IV-inhibitorer
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
BR0210030A (pt) Derivado de fenilpiridinacarbonilpiperazina
NO20002589D0 (no) Bifenylamidinderivater
DZ1724A1 (fr) Nouvelles azétidinones substituées comme agents anti-inflammatoires et anti-dégénérescence.
EP1422227A4 (de) Verfahren zur herstellung von pyridinverbindungen
DK0843967T3 (da) Anvendelse af beta-aminopripionsyrederivater som fungicider
AU1867792A (en) Improvements in or relating to organic compounds
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
DE69121259D1 (de) Beta-Lactam-Verbindungen und ihre Herstellung
ATE245147T1 (de) Substituierte aminochinazolinon (thion) derivate
ES2185599T3 (es) Preparacion de intermediarios de la imidazodiacepina.
ATE332892T1 (de) Zwischenverbindung für die herstellung von carvedilol
DE69511449D1 (de) Octahydro-2-Naphthalincarbonsäure-Derivate, ihre Herstellung und Verwendung
AU2003248059A1 (en) NOVEL Alpha-KETOAMIDE DERIVATIVE AND USE THEREOF
EP1466900A4 (de) 2-substituierte vitamin-d-derivate
TH50302A (th) พิแรโซลคาร์บอกซะไมด์และพิแรโซลไธโอเอไมด์ที่เป็นสารฆ่าเชื้อรา

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties